Evolus Inc's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Retained-Earnings" stands at -661.17 Million United States Dollars as of 09/30/2025, the lowest value at least since 03/31/2016, the period currently displayed.
As of the end of Evolus Inc's third quarter, the item "Retained Earnings" stands at -661.17 Million USD. This represents a decrease of -2.44 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -58.56 Million United States Dollars compared to the value the year prior.
The 1 year change is -58.56 Million United States Dollars.
The 3 year change is -197.30 Million United States Dollars.
The 5 year change is -395.79 Million United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Retained Earnings | 905,699,262,464.00 |
![]() | Johnson & Johnson - Retained Earnings | 486,508,953,600.00 |
![]() | AbbVie Inc - Retained Earnings | 399,570,305,024.00 |
![]() | Roche Holding AG - Retained Earnings | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Retained Earnings | 280,205,508,085.11 |